ViaLase Receives CE Mark for First Femtosecond Laser for the Treatment of Glaucoma, the ViaLase® Laser

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

ViaLase-CE

More Like This

PR Newswire associated0

ViaLase to Present at the 42nd Congress of the European Society of Cataract and Refractive Surgeons (ESCRS)

PR Newswire associated0

Adagio Medical Announces CE Mark approval of VT Cryoablation System, Plans for Immediate Commercialization in Select European Centers

PR Newswire associated0

Norlase Receives FDA 510(k) Clearance and CE Mark for LYNX™ Pattern Scanning Laser Indirect Ophthalmoscope

Sanoculis Receives CE Mark for MINT® Product for the Treatment of Glaucoma

MedLumics New CEO and Board Member Announces 10 Patients Treated in First in Man (FIM) Clinical Trial With the Real-Time Visually Guided AblaView PFA System

Evolution Optiks Secures CE Marking for Groundbreaking Eye Care Device

LumiThera Obtains FDA Authorization of Valeda Treatment for Dry AMD Patients to Improve Vision

LumiThera Provides Update on FDA Review of Valeda Treatment for Dry AMD Patients